The overlooked impact of nail psoriasis on quality of life

Nail psoriasis is a common but often overlooked manifestation of psoriasis, affecting up to 80% of patients with psoriatic skin lesions. In some cases, nail involvement may be the only sign of psoriasis, occurring in approximately 6% of patients. The condition is linked to more severe forms of psoriasis, earlier onset of the disease, and an increased risk of psoriatic arthritis, which underscores its significant impact on a patient’s quality of life. Common symptoms of nail psoriasis include pitting, onycholysis, oil drop discoloration, and subungual hyperkeratosis, with both the nail matrix and nail bed being affected.

Despite the high prevalence, nail psoriasis is notoriously difficult to treat due to the dense structure of the nail plate, which limits the penetration of topical therapies. Treatment options range from topical agents and intralesional injections to systemic and biologic therapies, but the effectiveness varies. Corticosteroids and vitamin D derivatives are frequently used, though intralesional injections can be painful. Systemic treatments, including methotrexate, retinoids, and biologics such as infliximab and adalimumab, show promise, especially in cases of severe or extensive nail involvement.

The complexity of managing nail psoriasis requires a personalized approach, considering the number of nails affected, the severity of symptoms, and any coexisting psoriatic arthritis or cutaneous psoriasis. Advancements in diagnostic tools, including dermoscopy and ultrasound, have improved the ability to assess and monitor nail psoriasis, offering hope for better outcomes with early and targeted interventions.